Skip to main content


Metabolic and Cardiovascular Diseases

Cardiovascular & Metabolic Diseases

Cardiovascular and metabolic diseases can have a substantial impact on patients, their families and healthcare systems.

We continue to challenge the way we think about these diseases and how we can improve health outcomes.


Diabetes is a chronic condition resulting from the body’s inability to sufficiently produce and/or properly use insulin.1 Insulin is a hormone that is produced by your pancreas, which is vital in regulating the body’s blood glucose (sugar) level.2

The two most common forms of diabetes are type 1 and type 2 diabetes. In type 1 diabetes, patients are unable to produce their own insulin. In type 2 diabetes, patients are unable to properly use the insulin that their body has produced, or their bodies do not create enough insulin.3

Possible complications associated with diabetes include cardiovascular disease, nerve damage, kidney damage and eye damage.4

As of 2020, approximately 3.7 million Canadians were diagnosed with type 1 or 2 diabetes and this number is expected to grow by 30%, to an estimated 4.9 million, by the year 2030.5

At Janssen, we are committed to the pursuit of solutions aimed at reshaping disease prevention, diagnosis, and treatment options for patients with cardiovascular and metabolic diseases.